Secondary hypertension as a cause of treatment resistance

References

• Sudano I, Beuschlein F, Lüscher TF, et al. Secondary causes of hypertension. In : A.J. Camm editor The ESC textbook of cardiovascular medicine. (3 edn), . 2018. p. 1–9. Oxford, UK: Publisher Oxford University Press.
   Google Scholar
• Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, and how to screen? Eur Heart J. 2014;35(19):1245–1254. doi: 10.1093/eurheartj/eht534.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi: 10.1093/eurheartj/ehy339.
   PubMed Web of Science ®Google Scholar
• Muntner P, Miles MA, Jaeger BC, et al. Blood pressure control among US adults, 2009 to 2012 through 2017 to 2020. Hypertension. 2022;79(9):1971–1980. doi: 10.1161/HYPERTENSIONAHA.122.19222.
   PubMed Web of Science ®Google Scholar
• Grassi G, Mark A, Esler M. The sympathetic nervous system alterations in human hypertension. Circ Res. 2015;116(6):976–990. doi: 10.1161/CIRCRESAHA.116.303604.
   PubMed Web of Science ®Google Scholar
• Parati G, Esler M. The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J. 2012;33(9):1058–1066. doi: 10.1093/eurheartj/ehs041.
   PubMed Web of Science ®Google Scholar
• Yang T, Xu C. Physiology and pathophysiology of the intrarenal Renin-Angiotensin system: an update. J Am Soc Nephrol. 2017;28(4):1040–1049. doi: 10.1681/ASN.2016070734.
   PubMed Web of Science ®Google Scholar
• Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344(6):431–442. doi: 10.1056/NEJM200102083440607.
   PubMed Web of Science ®Google Scholar
• Patel SM, Li J, Parikh SA. Renal artery stenosis: optimal therapy and indications for revascularization. Curr Cardiol Rep. 2015;17(9):623. doi: 10.1007/s11886-015-0623-7.
   PubMed Web of Science ®Google Scholar
• Cooper CJ, Murphy TP, Cutlip DE, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370(1):13–22. doi: 10.1056/NEJMoa1310753.
   PubMed Web of Science ®Google Scholar
• Jenks S, Yeoh SE, Conway BR. Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis. Cochrane Database Syst Rev. 2014;2014(12):CD002944.
   PubMedGoogle Scholar
• Prince M, Tafur JD, White CJ. When and how should we revascularize patients with atherosclerotic renal artery stenosis? JACC Cardiovasc Interv. 2019;12(6):505–517. doi: 10.1016/j.jcin.2018.10.023.
   PubMed Web of Science ®Google Scholar
• Arlt W. A detour guide to the endocrine society clinical practice guideline on case detection, diagnosis and treatment of patients with primary aldosteronism. Eur J Endocrinol. 2010;162(3):435–438. doi: 10.1530/EJE-09-0869.
   PubMed Web of Science ®Google Scholar
• Conn JW, Louis LH. Primary aldosteronism: a new clinical entity. Trans Assoc Am Physicians. 1955;68:215–231; discussion, 231-3.
   PubMedGoogle Scholar
• Gruber S, Beuschlein F. Hypokalemia and the prevalence of primary aldosteronism. Horm Metab Res. 2020;52(6):347–356. doi: 10.1055/a-1134-4980.
   PubMed Web of Science ®Google Scholar
• Reincke M, Fischer E, Gerum S, et al. Observational study mortality in treated primary aldosteronism: the German conn’s registry. Hypertension. 2012;60(3):618–624. doi: 10.1161/HYPERTENSIONAHA.112.197111.
   PubMed Web of Science ®Google Scholar
• Meng Z, Dai Z, Huang K, et al. Long-term mortality for patients of primary aldosteronism compared With essential hypertension: a systematic review and meta-analysis. Front Endocrinol. 2020;11:121. doi: 10.3389/fendo.2020.00121.
   PubMed Web of Science ®Google Scholar
• Mulatero P, Monticone S, Burrello J, et al. Guidelines for primary aldosteronism: uptake by primary care physicians in Europe. J Hypertens. 2016;34(11):2253–2257. doi: 10.1097/HJH.0000000000001088.
   PubMed Web of Science ®Google Scholar
• Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889–1916. doi: 10.1210/jc.2015-4061.
   PubMed Web of Science ®Google Scholar
• Mulatero P, Bertello C, Sukor N, et al. Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism. Hypertension. 2010;55(3):667–673. doi: 10.1161/HYPERTENSIONAHA.109.146613.
   PubMed Web of Science ®Google Scholar
• Schieda N, Siegelman ES. Update on CT and MRI of adrenal nodules. AJR Am J Roentgenol. 2017;208(6):1206–1217. doi: 10.2214/AJR.16.17758.
   PubMed Web of Science ®Google Scholar
• Loriaux DL. Diagnosis and differential diagnosis of cushing’s syndrome. N Engl J Med. 2017;377(2):e3.
   PubMedGoogle Scholar
• Pappachan JM, Hariman C, Edavalath M, et al. Cushing’s syndrome: a practical approach to diagnosis and differential diagnoses. J Clin Pathol. 2017;70(4):350–359. doi: 10.1136/jclinpath-2016-203933.
   PubMed Web of Science ®Google Scholar
• Nieman LK, Biller BMK, Findling JW, et al. The diagnosis of cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(5):1526–1540. doi: 10.1210/jc.2008-0125.
   PubMed Web of Science ®Google Scholar
• Fleseriu M, Auchus R, Bancos I, et al. Consensus on diagnosis and management of cushing’s disease: a guideline update. Lancet Diabetes Endocrinol. 2021;9(12):847–875. doi: 10.1016/S2213-8587(21)00235-7.
   PubMed Web of Science ®Google Scholar
• Prete A, Subramanian A, Bancos I, et al. Cardiometabolic disease burden and steroid excretion in benign adrenal tumors: a cross-sectional multicenter study. Ann Intern Med. 2022;175(3):325–334. doi: 10.7326/M21-1737.
   PubMed Web of Science ®Google Scholar
• Lenders JWM, Duh Q-Y, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915–1942. doi: 10.1210/jc.2014-1498.
   PubMed Web of Science ®Google Scholar
• Mazza A, Beltramello G, Armigliato M, et al. Arterial hypertension and thyroid disorders: what is important to know in clinical practice? Ann Endocrinol. 2011;72(4):296–303. doi: 10.1016/j.ando.2011.05.004.
   PubMed Web of Science ®Google Scholar
• Streeten DH, Anderson GH, Howland T, et al. Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. Hypertension. 1988;11(1):78–83. doi: 10.1161/01.hyp.11.1.78.
   PubMed Web of Science ®Google Scholar
• Fraser WD. Hyperparathyroidism. Lancet. 2009;374(9684):145–158. doi: 10.1016/S0140-6736(09)60507-9.
   PubMed Web of Science ®Google Scholar
• Schiffl H, Lang SM. Hypertension secondary to PHPT: cause or coincidence? Int J Endocrinol. 2011;2011:974647. doi: 10.1155/2011/974647.
   PubMed Web of Science ®Google Scholar
• Peacock E, Krousel-Wood M. Adherence to antihypertensive therapy. Med Clin North Am. 2017;101(1):229–245. doi: 10.1016/j.mcna.2016.08.005.
   PubMed Web of Science ®Google Scholar
• Corrao G, Parodi A, Nicotra F, et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens. 2011;29(3):610–618. doi: 10.1097/HJH.0b013e328342ca97.
   PubMed Web of Science ®Google Scholar
• Bangalore S, Ley L. Improving treatment adherence to antihypertensive therapy: the role of single-pill combinations. Expert Opin Pharmacother. 2012;13(3):345–355. doi: 10.1517/14656566.2012.652086.
   PubMed Web of Science ®Google Scholar
• Gupta P, Patel P, Štrauch B, et al. Biochemical screening for nonadherence Is associated with blood pressure reduction and improvement in adherence. Hypertension. 2017;70(5):1042–1048. doi: 10.1161/HYPERTENSIONAHA.117.09631.
   PubMed Web of Science ®Google Scholar
• Burnier M, Wuerzner G, Struijker-Boudier H, et al. Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertension. 2013;62(2):218–225. doi: 10.1161/HYPERTENSIONAHA.113.00687.
   PubMed Web of Science ®Google Scholar
• Parati G, Lombardi C, Hedner J, et al. Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the european society of hypertension, by the European respiratory society and by the members of European COST (COoperation in scientific and technological research) ACTION B26 on obstructive sleep apnea. J Hypertens. 2012;30(4):633–646. doi: 10.1097/HJH.0b013e328350e53b.
   PubMed Web of Science ®Google Scholar
• Grassi G, Seravalle G, Brambilla G, et al. Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea. J Hypertens. 2014;32(2):383–388. doi: 10.1097/HJH.0000000000000034.
   PubMed Web of Science ®Google Scholar
• Iftikhar IH, Valentine CW, Bittencourt LRA, et al. Effects of continuous positive airway pressure on blood pressure in patients with resistant hypertension and obstructive sleep apnea: a meta-analysis. J Hypertens. 2014;32(12):2341–2350; discussion 2350. doi: 10.1097/HJH.0000000000000372.
   PubMed Web of Science ®Google Scholar
• Bratton DJ, Gaisl T, Wons AM, et al. CPAP vs mandibular advancement devices and blood pressure in patients with obstructive sleep apnea: a systematic review and meta-analysis. JAMA. 2015;314(21):2280–2293. doi: 10.1001/jama.2015.16303.
   PubMed Web of Science ®Google Scholar
• Shantha GP, Pancholy SB. Effect of renal sympathetic denervation on apnea-hypopnea index in patients with obstructive sleep apnea: a systematic review and meta-analysis. Sleep Breath. 2015;19(1):29–34. doi: 10.1007/s11325-014-0991-z.
   PubMed Web of Science ®Google Scholar